- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03386188
Role of the Posterior Parietal Cortex in the Processing of Sensory Information (CORTEX)
April 17, 2026 updated by: University Hospital, Lille
Role of the Posterior Parietal Cortex in the Processing of Sensory Information Modulating the Excitability of the Primary Motor Cortex in Humans
Although the primary motor cortex is considered has the common final pathway of motor commands, it is influenced by several structures as, for example, the premotor cortex and the posterior parietal cortex which are involved in motor planning and programming and which integrates movement-induced sensory impute (parieto-frontal circuits).
Several studies have shown that there are some direct functional connections between the premotor cortex and the posterior parietal cortex and from these two regions to the primary motor cortex.
The posterior parietal cortex can then be considered as a sensorimotor interface whose function in planification and motor control of upper limb is well demonstrated.
The hypothesis is that the posterior parietal cortex could participate to the modulation of motor cortex excitability by proprioceptive sensory inputs namely long latency afferent inhibition and afferent induced facilitation.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lille, France
- Hôpital Roger Salengro, CHRU de Lille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Right handed
- No neurological troubles
- Informed consent signed
- Affiliated to a social security
Exclusion Criteria:
- Psychiatric antecedent
- Neurological disease
- Contra-indication to TMS
- Under psychiatric treatment
- Pregnancy
- Contra-indication to MRI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy arm
posterior parietal cortex (PPC) transitory inactivation
|
Transitory inactivation of the posterior parietal cortex and measure of sensorimotor integration.
Electrodes for the collection of EMG activity will be glued on the skin next to the first interosseus dorsalis muscle, the Abductor digiti minimi, the Extensor carpi radialis and the Abductor pollicis brevis.
EMG signals will be stored on computer for off-line analysis using Signal © software (Cambridge Electronic Design, Cambridge, UK)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Afferent induced facilitation
Time Frame: Baseline
|
Motor cortex facilitation following median nerve stimulation at interstimulus intervals of 70ms
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interaction between long latency afferent inhibition and long latency intracortical inhibition (LICI)
Time Frame: Baseline
|
Effect of median nerve stimulation on LICI at 100ms interval
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philippe Derambure, MD, PhD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 8, 2016
Primary Completion (Actual)
July 18, 2021
Study Completion (Actual)
July 18, 2021
Study Registration Dates
First Submitted
December 14, 2017
First Submitted That Met QC Criteria
December 20, 2017
First Posted (Actual)
December 29, 2017
Study Record Updates
Last Update Posted (Actual)
April 22, 2026
Last Update Submitted That Met QC Criteria
April 17, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014_32
- 2014-A01507-40 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subject
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Changchun GeneScience Pharmaceutical Co., Ltd.Completed
-
CelltrionCompletedHealthy SubjectKorea, Republic of
-
Staidson (Beijing) Biopharmaceuticals Co., LtdCompleted
-
GeneScience Pharmaceuticals Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingHealthy SubjectUnited States
-
Hospices Civils de LyonCompleted
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingHealthy SubjectUnited States
-
Yuhan CorporationCompletedHealthy SubjectKorea, Republic of
Clinical Trials on Transcranial Magnetic Stimulation (TMS)
-
University of ManitobaRecruiting
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Beth Israel Deaconess Medical CenterTerminated
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed
-
VA Office of Research and DevelopmentNot yet recruiting
-
Northwestern UniversityCompletedHealthyUnited States
-
University of FloridaCompleted
-
Huashan HospitalUnknown
-
Centre Hospitalier St AnneRecruitingTreatment Resistant SchizophreniaFrance
-
University of California, San DiegoNational Institutes of Health (NIH)CompletedMajor Depressive DisorderUnited States, Australia